Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baxter International Inc (BAX) vs Goldman Sachs Group Inc (GS) Price & Performance

Baxter International IncTrade
Goldman Sachs Group IncTrade

Price performance (Past 24H)

Key statistics

Baxter International Inc vs Goldman Sachs Group Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.36B), while Goldman Sachs Group Inc trades at $1,035.91 (market cap $301.22B). The key difference: Goldman Sachs Group Inc is far larger — about 21× Baxter International Inc's market cap, and Goldman Sachs Group Inc pays the higher dividend (1.93%). Which is the better fit depends on your goals.

BAXGS
Market Cap
$14.36B$301.22B
Sector
HealthFinancials
52-Week High
$28.35$1.15K
52-Week Low
$15.80$715.95
Enterprise Value
$21.88B
Dividend Yield
0.14%1.93%
Volume
2,592,735

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Baxter International Inc

No Aura AI signal available yet.

Goldman Sachs Group Inc

Goldman Sachs (GS) trades at $1,034.41, down 0.5% on the day, with a neutral technical signal. The company shows strong fundamental momentum with three consecutive quarterly EPS beats and revenue growth accelerating to $58.3B in 2025. Analyst consensus is mixed with 40% buy ratings but a $1,160 price target suggesting 12% upside potential. Recent news highlights Goldman's leadership role in major upcoming IPOs including Anthropic, SpaceX, and OpenAI.

The outlook remains positive given Goldman's positioning in the upcoming AI IPO wave and strong investment banking pipeline. Key risks include volatile cash flow patterns with negative operating cash flow in recent periods and market sensitivity to interest rate changes. The stock appears reasonably valued at 16x P/E with 31.7% net margins supporting further upside if earnings momentum continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX

About Goldman Sachs Group Inc

The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.

Read more on GS